1. Home
  2. BIAF vs EPWK Comparison

BIAF vs EPWK Comparison

Compare BIAF & EPWK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BIAF
  • EPWK
  • Stock Information
  • Founded
  • BIAF 2014
  • EPWK 2011
  • Country
  • BIAF United States
  • EPWK China
  • Employees
  • BIAF N/A
  • EPWK N/A
  • Industry
  • BIAF Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • EPWK
  • Sector
  • BIAF Health Care
  • EPWK
  • Exchange
  • BIAF Nasdaq
  • EPWK Nasdaq
  • Market Cap
  • BIAF 12.2M
  • EPWK 11.1M
  • IPO Year
  • BIAF 2022
  • EPWK 2025
  • Fundamental
  • Price
  • BIAF $0.23
  • EPWK $0.43
  • Analyst Decision
  • BIAF Hold
  • EPWK
  • Analyst Count
  • BIAF 1
  • EPWK 0
  • Target Price
  • BIAF N/A
  • EPWK N/A
  • AVG Volume (30 Days)
  • BIAF 706.3K
  • EPWK 400.5K
  • Earning Date
  • BIAF 08-14-2025
  • EPWK 05-27-2025
  • Dividend Yield
  • BIAF N/A
  • EPWK N/A
  • EPS Growth
  • BIAF N/A
  • EPWK N/A
  • EPS
  • BIAF N/A
  • EPWK N/A
  • Revenue
  • BIAF $7,681,059.00
  • EPWK $20,164,008.00
  • Revenue This Year
  • BIAF N/A
  • EPWK N/A
  • Revenue Next Year
  • BIAF $20.00
  • EPWK N/A
  • P/E Ratio
  • BIAF N/A
  • EPWK N/A
  • Revenue Growth
  • BIAF 4.99
  • EPWK 10.25
  • 52 Week Low
  • BIAF $0.16
  • EPWK $0.41
  • 52 Week High
  • BIAF $2.26
  • EPWK $26.00
  • Technical
  • Relative Strength Index (RSI)
  • BIAF 32.85
  • EPWK N/A
  • Support Level
  • BIAF $0.27
  • EPWK N/A
  • Resistance Level
  • BIAF $0.30
  • EPWK N/A
  • Average True Range (ATR)
  • BIAF 0.02
  • EPWK 0.00
  • MACD
  • BIAF -0.01
  • EPWK 0.00
  • Stochastic Oscillator
  • BIAF 2.58
  • EPWK 0.00

About BIAF bioAffinity Technologies Inc.

bioAffinity Technologies Inc addresses the need for noninvasive diagnosis of early-stage cancer and diseases of the lung and targeted cancer treatment. It develops proprietary noninvasive diagnostic tests and cancer therapeutics using technology that preferentially targets cancer cells and cell populations indicative of a diseased state. The company's product, CyPath Lung, is a noninvasive test for the detection of early-stage lung cancer.

About EPWK EPWK Holdings Ltd. Class A Ordinary Shares

EPWK Holdings Ltd create an innovative and efficient crowdsourcing platform to connect businesses with great talents. It operates online marketplace to enable businesses (buyers) and service providers (sellers) to find each other. The platform users consist of buyers who seek talents for their jobs and sellers who offer different talents and skills. The company derives revenue mainly comes from providing various value-added services for users on both supply and demand sides.

Share on Social Networks: